by Leanne Talbot | Mar 29, 2019
In October, Hackney Council unanimously passed a motion on rare and uncommon cancer. On the 28th March, City and Hackney Clinical Commissioning Group and Hackney Council, held a joint “rare and uncommon cancer” seminar with presentations and discussions on... by Leanne Talbot | Mar 25, 2019
Who we are, how we see ourselves – how we feel and think about our selves, our relationships, our community, and the world at large – all influence how we interact, involve and respond to ourselves, others and life’s events. How we think and feel is... by Leanne Talbot | Mar 22, 2019
On the 20th March 2019 the NET Patient Foundation attended the ‘Theranostics is here and now’ meeting, arranged by the Royal Free Hospital and University College London UCL). The meeting was an update by recognised experts highlighting advances in nuclear... by Leanne Talbot | Mar 14, 2019
Catherine Bouvier, NPF’s Chief Executive, attended the European Neuroendocrine Tumor Society 16th Annual Conference which was held in Barcelona on 6th-8th March. ENETs this year had a real flavour of change. The advocacy issues were championed by both... by Leanne Talbot | Mar 6, 2019
Failing to enrol patients into clinical trials can dramatically delay the development of new treatments. Currently 80% of all clinical trials (not just NET), fail to hit their full enrolment target. The NET Patient Foundation is working with the iCancer group... by Leanne Talbot | Mar 6, 2019
The NET Patient Foundation and the Association for Multiple Endocrine Neoplasia Disorders (AMEND) are developing a joint research strategy to ensure that each charity’s research funds are directed towards the most appropriate areas of research. As a patient, your... 